Pcyt2+/− were investigated at 2 and 6–8 months (mo) of age and in addition, 6-mo old Pcyt2+/− with developed NASH were supplemented with PEA for 8 weeks and glucose and fatty acid metabolism, insulin signaling, and inflammation were examined. Here, PCYT2 is linked to metabolic dysfunction-associated steatohepatitis.